An observational study in COVID-19 and Periodontitis, sponsored by University of Belgrade. Status unknown at 1 site in Serbia. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-01-25.
Sponsored by University of Belgrade · Observational
Aims are to assess periodontal health and salivary stress/ immunity responses in COVID-19 survivors
There are lack of data concerning oral health in COVID-19 survivors, nevertheless, many middle-aged patients with oral symptoms of Post-acute COVID-19 report xerostomia and taste impairment and suffer from oral hypofunction, thus may be susceptible to periodontitis and oral frailty. Post-acute or long COVID-19 is/would be the health hallmark of post-COVID-19 era, manifested as a multiplicity of clinical problems and requiring conceptual framework aiming at multidisciplinary health preserving activities. There are various factors which may affect oral and periodontal health in post-COVID-19 era, such as disruption of dental professional care due to the fear of infection, virus-induced disturbance of oral homeostasis and, as a common denominator- COVID-19-induced psychological stress. Expected results would not just offer epidemiological data but also, mechanistic background for defining risks and modified measures aiming to preserve oral health in post-COVID-19 era.
7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.
This study's planned enrollment of 210 is below the median of 261 across 3,136 observational studies indexed under COVID-19.
Browse COVID-19 studies →University of Belgrade is the lead sponsor of 70 studies on the registry; 14 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Groups I and III will include COVID-19 survivors in late convalescent stage (one to six months post onset of symptoms accompanied by SARS-CoV-2- positive nasopharyngeal swab result) who had non-severe COVID-19 (no or mild pneumonia - less than 50 percent lung involvement on imaging within 24 to 48 hours, absence of dyspnea and hypoxia). Groups II and IV will include participants who report to had no symptoms of COVID-19 and had no SARS-CoV-2- positive nasopharyngeal swab result
Exclusion Criteria:
Participants in the late convalescent stage of COVID-19 with diagnosed periodontitis
Participants with diagnosed periodontitis and no history of COVID-19
Participants in the late convalescent stage of COVID-19 without periodontitis
Participants with no history of COVID-19 and without periodontitis
Periodontal disease stage and COVID 19
Correlation periodontitis and COVID 19 infection
Time frame: one to six months after COVID-19
Oral frailty
Oral frailty assessment in Covid 19 and Perio affected patients
Time frame: one to six months after COVID-19
psychological stress
Assessment of psychological stress
Time frame: one to six months after COVID-19
salivary stress/immunity mediators
Association of salivary stress/immunity mediators levels with perio disease in COVID 19 patients
Time frame: one to six months after COVID-19
This study is status unknown, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Belgrade